Julia K Warnock
University of Oklahoma
Built from public records under this name as ClinicalTrials.gov spells it. A name can belong to more than one person, so each section says how its rows were tied to this name. No contact details are shown.
Trials
Studies that name Julia K Warnock as principal investigator, study chair or study director, newest first. Live from ClinicalTrials.gov, fetched 2026-11-12 01:53 UTC. Open this list on ClinicalTrials.gov
- N/ANCT00425711 · Study of Acamprosate in Driving Under the Influence (DUI) Court ParticipantsUniversity of Oklahoma · terminated · Alcohol Dependence · principal investigator
Grants
NIH projects from RePORTER, fetched 2026-11-12 01:53 UTC. A project is listed only when its grant number is on one of the trials above, or when the awardee institution matches an affiliation the registry gives for this name. Coverage is US federal funding only; UK and EU funders are not searched yet.
No NIH project could be tied to this name by a shared trial or a matching institution.
Most cited trial papers
Clinical-trial papers with this author name, ranked by citations from NIH iCite, fetched 2026-11-12 01:53 UTC. The ranking covers the 200 most relevant of 4 PubMed records, and a shared surname and initials can bring in a namesake. All 4 on PubMed
- A placebo-controlled trial of bupropion SR as an antidote for selective serotonin reuptake inhibitor-induced sexual dysfunction.J Clin Psychiatry · 2004138 citationsRCR 4.8
- 43 citationsRCR 1.4
- Depressive mood symptoms associated with ovarian suppression.Fertil Steril · 200028 citationsRCR 1.0
- Sertraline in the treatment of depression associated with gonadotropin-releasing hormone agonist therapy.Biol Psychiatry · 199820 citationsRCR 0.8